CALVENZA 03 EIV/EHV(Boehringer-Ingelheim) Single Dose loaded in a syringe with needle. A killed virus vaccine that provides protection against rhinopneumonitis respiratory disease caused by EHV-4 and EHV-1. Also provides immunity against equine flu types A1, A2 And cross-protects against all other equine influenza strains.

PLEASE DO NO CONFUSE THIS VACCINE WITH CALVENZA EIV WHICH ONLY OFFERS PROTECTION AGAINST FLU OR CALVENZA EHV WHICH ONLY PROTECTS AGAINST EHV-1 AND EHV-4

Features:

Unique EHV-1 equine respiratory origin isolate.

Stimulates antibody to EHV-1 And EVH-4.

Proven efficacious against EHV-1 And EHV-4 in challenge studies.

Incorporates North American (Kentucky/95) And Eurasian (Newmarket/2/93) EIV A₁ And A₂ strains.

Efficacy based on challenge studies for EIV. Novel adjuvant.

Safe, all killed vaccine. Includes innovative pliable nasal applicator.

Benefits:

Flexible dose administration.

Three dose regimen conforms to AAEP recommendations.

No reversion to virulence concern.

Minimal vaccine site reactions.

Advantages: Calvenza EIV/EHV is proven safe. Calvenza EIV/EHV is proven effective by challenge.

Dosage And Administration: Using aseptic technique inoculate horses IM with a 2 mL dose. Administer a second 2 mL dose IM in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks either IM or IN. Revaccinate annually.



Uses: For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4) and by equine influenza types A₁ and A₂.

IMPORTANT: IF THE VACCINE PART OF YOUR ORDER IS LESS THAN $350 THEN YOU WILL BE CHARGED A SECOND DAY AIR SHIPPING COST OF $21.95 TO ALL 48 CONTINENTAL STATES


THESE SECOND DAY AIR VACCINE SHIPMENTS ARE ONLY SHIPPED ON MONDAY, TUESDAY, AND WEDNESDAY IN A STYRAFOAM CONTAINER WITH ICE PACKS